Kong, Li Ren http://orcid.org/0000-0001-7980-4666
Mohamed Salleh, Nur Afiqah Binte
Ong, Richard Weijie
Tan, Tuan Zea http://orcid.org/0000-0001-6624-1593
Syn, Nicholas L. http://orcid.org/0000-0002-6343-176X
Goh, Robby Miguel
Fhu, Chee Wai
Tan, Daniel S. W.
Iyer, N. Gopalakrishna
Kannan, Srinivasaraghavan http://orcid.org/0000-0002-9539-5249
Verma, Chandra S.
Lim, Yaw Chyn
Soo, Ross
Ho, Jingshan
Huang, Yiqing
Lim, Joline S. J.
Yan, Benedict Junrong
Nga, Min En
Lim, Seng Gee
Koeffler, H. Phillip
Lee, Soo Chin
Kappei, Dennis http://orcid.org/0000-0002-3582-2253
Hung, Huynh The
Goh, Boon Cher http://orcid.org/0000-0002-4107-102X
Funding for this research was provided by:
MOH | National Medical Research Council (NMRC/CG/012/2013, NMRC/CG/012/2013)
Article History
Received: 19 May 2019
Accepted: 25 February 2020
First Online: 25 March 2020
Competing interests
: S.K. and C.S.V. are the founder directors of Sinopsee therapeutics, a biotech company developing molecules for therapeutic purposes; this work has no conflict with the company. The remaining authors declare no competing interests.